Immune mechanisms associated with the rejection of fetal murine proislet allografts and pig proislet xenografts: Comparison of intragraft cytokine mRNA profiles

Transplantation

Volumn 67, Issue 7, 1999, Pages 963-971

  Simeonovic, Charmaine J ^a   Townsend, Michelle J ^a   Morris, Carolyn F ^a   Hapel, Andrew J ^a   Fung, Ming Chiu ^c   Mann, David A ^a   Young, Ian G ^a   Wilson, J Dennis ^b  

^a Biology and Environment   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GRAFT REJECTION; HISTOPATHOLOGY; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; CYTOKINES; FETAL TISSUE TRANSPLANTATION; FETUS; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; RNA, MESSENGER; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033560772     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904150-00006     Document Type: Article

References (57)

1. + T cell in allograft rejection. J Immunol 1987; 139: 4022.
2. + cells in islet allograft rejection. Transplantation 1990; 50: 120.
3. Simeonovic CJ, Brown DJ, Townsend MJ, Wilson JD. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression. Cell Transplant 1996; 5: 525.
4. + T cells trigger rejection of grafts expressing class I major histocompatibility complex alloantigens. Transplant Proc 1986; 18: 310.
5. + T-lymphocytes in rejection by mice of fetal pig proislet xenografts. Diabetes 1989; 38(suppl 1): 217.
6. + T cell-depleted diabetic mice. Transplantation 1990; 50: 657.
7. Morris CF, Simeonovic CJ, Fung M-C, Wilson JD, Hapel AJ. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. J Immunol 1995; 154: 2470.
8. + T lymphocyte-deficient mice. Transplantation 1993; 55: 718.
9. + T cells. Immunol Rev 1991; 123: 209.
10. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J.Immunol 1993; 150: 1093.
11. Simeonovic CJ, Lafferty KJ. Immunogenicity of mouse fetal pancreas and proislets. A comparison. Transplantation 1988; 45: 824.
12. Simeonovic CJ, Brown DJ, Teittinen KUS, Wilson JD. Preparation and transplantation of fetal proislets. In: Ricordi C, ed. Pancreatic islet cell transplantation. Austin: RG Landes Co., 1992: 238.
13. Kirkman RL, Colvin RB, Flye MW, et al. Transplantation in miniature swine VI.: factors influencing survival of renal allografts. Transplantation 1979; 28: 18.
14. + T cell-depleted mice. Transplantation 1990; 49: 849.
15. Dialynas DP, Quan ZS, Wall KA, et al. Characterisation of the murine T cell surface molecule designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.
16. Hogarth PM, Edwards J, McKenzie IFC, Goding JW, Liew FY. Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology 1982; 46: 135.
17. +) subsets among anti-Ia cytolytic T cell clones. J Immunol 1984; 132: 2775.
18. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63.
19. Warren HS, Hodder MJ, Allan W, Hume DA, Simeonovic CJ. Induction of class II major histocompatibility antigens on thyroid, adult pancreatic islet and fetal proislet allografts. Transplantation 1992; 53: 834 .
20. Simeonovic CJ, Townsend MJ, Wilson JD, et al. Eosinophils are not required for the rejection of neovascularised fetal pig proislet xenografts in mice. J Immunol 1997; 158: 2490.
21. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294 .
22. Montgomery RA, Dallman MJ. Analysis of cytokine expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 1991; 147: 554.
23. Ralph P, Moore MAS, Nilsson K. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp.Med 1976; 143: 1528.
24. Kaye J, Porchelli S, Tite J, Jones B, Janeway CA Jr. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J Exp Med 1983; 158: 836.
25. Wren SM, Wang SC, Thai NL, et al. Evidence for early Th2 T cell predominance in xenoreacivity. Transplantation 1993; 56: 905.
26. Auchincloss H Jr. Xenogeneic transplantation. Transplantation 1988; 46: 1.
27. Benda B, Karlsson-Parra A, Ridderstad A, Korsgren O. Xenograft rejection of porcine islet-like cell clusters in immunoglobulin-or Fc-receptor γ-deficient mice. Transplantation 1996; 62: 1207.
28. Simeonovic CJ, McKenzie KUS, Wilson JD, Zarb JC, Hodgkin PD. Role of anti-donor antibody in the rejection of pig proislet xenografts in mice. Xenotransplantation 1998; 5: 18.
29. Benfield MR, Witson JC, Alter BJ, Bach FH. Murine APC activation in the xenogeneic MLC. Scand J Immunol 1993; 38: 130.
30. Cunningham AC, Butler TJ, Kirby JA. Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes. Immunology 1994; 81: 268.
31. Weir MR, Hall-Craggs M, Shen SY, et al. The prognostic value of the eosinophil in acute renal allograft rejection. Transplantation 1986; 41: 709.
32. Foster PF, Sankary HN, Hart M, Ashmann M, Williams JW. Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation 1989; 47: 72.
33. Martinez OM, Ascher NL, Ferrell L, et al. Evidence for a non-classical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 1993; 55: 909.
34. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501.
35. Spry CJF, Kay AB, Gleich G. J Eosinophils. Immunol Today 1992; 13: 384.
36. Lopez AF, Sanderson CJ, Gamble JR, et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167: 219.
37. + T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271.
38. Hao L, Wang Y, Gill RG, et al. Role of lymphokine in islet allograft rejection. Transplantation 1990; 49: 609.
39. Ahmed KR, Guo TB, Gaal KK. Islet rejection in perforin-deficient mice. The role of perforin and Fas. Transplantation 1997; 63: 951.
40. Steiger J, Nickerson PW, Steurer, W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J Immunol1995; 155: 489.
41. Wogensen L, Xiaojian H, Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993; 178: 175.
42. Chen W-F, Zlotnick A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528.
43. Lenschow DJ, Zeng Y, Hathcock KS, et al. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60: 1171.
44. Wolf LA, Coulombe M, Gill RG. Donor antigen-presenting cell-independent rejection of islet xenografts. Transplantation 1995; 60: 1164.
45. + T helper cells and self antigen-presenting cells in the mouse. J Exp Med 1990; 172: 567.
46. Yoshizawa K, Yano A. Mouse T lymphocyte proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR. J Immunol 1984; 132: 2820.
47. Chang T-L, Shea CM, Urioste S, Thompson RC, Boom WH, Abbas AK. Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. J Immunol 1990; 145: 2803.
48. Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 1991; 146: 1750.
49. Schmitz J, Assenmacher M, Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993; 23: 191.
50. Doherty TM, Coffman RL. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J Immunol 1993; 150: 5476.
51. Sacks DL, Scott PA, Asofsky R, Sher AF. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol 1984; 132: 2072.
52. Lederer JA, Perez VL, DesRoches L, Kim SM, Abbas AK, Lichtman AH. Cytokine transcriptional events during helper T cell subset differentiation. J Exp Med 1996; 184: 397.
53. Steinman RM, Gutchinov B, Witmer MD, Nussenzweig MC. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J Exp Med 1983; 157: 613.
54. Setum CM, Hegre OD, Serie JR, Moore WV. The potency of splenic dendritic cells as alloantigen presenters in vivo. Transplantation 1990; 49: 1175.
55. Heufler C, Koch F, Stanzl U, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper cells. Eur J Immunol 1996; 26: 659.
56. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185: 317.
57. Austyn JM. Lymphoid dendritic cells. Immunology 1987; 62: 161.